Shanghai Branch of Alphamab Oncology was established in June 2018, and the office is located on the bustling Pudong Century Avenue. The Shanghai branch is mainly composed of colleagues from the clinical development department, including clinical operations, medical department, drug safety, data management, statistics and other function teams. The team can scientifically support the formulation of clinical development strategies for the company's core products including KN026, JSKN003, JSKN016 and JSKN033, and conduct a series of clinical trials with high efficiency and high quality.
Beijing Branch of Alphamab Oncology was established at the end of 2018 and is located in the prosperous International Trade Center district. Its main function is to support the company's clinical development and regulatory affairs. Beijing branch, jointly with Suzhou head office and Shanghai branch, undertake the clinical development of core products including KN026, JSKN003, JSKN016 and JSKN033. It mainly includes the medical department, clinical operation department, data management and regulatory affairs etc.
